
NHI Stock Forecast & Price Target
NHI Analyst Ratings
Bulls say
National Health Investors Inc. has raised its normalized funds from operations (NFFO) estimates for 2025 to $4.80 per share, reflecting a positive revision driven by a strong performance in Q2 2025 and an optimistic outlook from management. Additionally, the company's 2026 FFO estimate has also been increased to $5.03 per share, surpassing the consensus estimate while indicating anticipated year-over-year growth rates of 5.3% for 2025 and 4.8% for 2026. These upward adjustments in financial forecasts suggest a robust operational performance and future growth potential, contributing to a favorable outlook for the stock.
Bears say
The analysis indicates that National Health Investors Inc. faces a negative outlook primarily due to anticipated lower earnings growth over the next few years, which stems from a combination of accretive acquisition activities and potential operational issues among its operators. Additionally, the company could experience underperformance if the rent reset for NHC does not meet investor expectations, along with risks associated with deferred rent collections and challenges faced by operators, particularly in light of potential pandemic-related disruptions. These factors collectively suggest a cautious financial environment for National Health Investors, impacting overall revenue and profitability prospects.
This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.
NHI Analyst Forecast & Price Prediction
Start investing in NHI
Order type
Buy in
Order amount
Est. shares
0 shares